/
/
/

Anlon Healthcare Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---43%
---42%
---80%
22%22%22%19%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
AUROPHARMA
DRREDDY
LUPIN
MANKIND
AHCL
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,840₹447236 Cr36.9812.0762.82₹11479 Cr
9,322₹249673 Cr85.3634.04128.41₹2568 Cr
4,965.5₹187460 Cr85.9516.7297.06₹2163 Cr
1,119.1₹111521 Cr24.719.4262.53₹5040 Cr
1,366₹111484 Cr33.089.7757.87₹3879 Cr
1,969₹104604 Cr95.676.829.25₹889 Cr
1,679.8₹96031 Cr25.8717.9596.84₹3505 Cr
1,165.5₹95220 Cr29.555.3263.99₹4196 Cr
2,095₹94883 Cr17.1630.95154.36₹5333 Cr
2,280₹92770 Cr45.4213.7571.08₹1913 Cr
19.57₹933 Cr32.730.130.57₹29 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Jun 2025Mar 2025
₹88 Cr₹51 Cr₹33 Cr₹49 Cr
₹6 L₹1 L₹1 L₹4 L
₹88 Cr₹51 Cr₹33 Cr₹49 Cr
₹73 Cr₹36 Cr₹27 Cr₹33 Cr
₹16 Cr₹15 Cr₹6 Cr₹17 Cr
₹93 L₹57 L₹82 L₹91 L
₹14 Cr₹14 Cr₹5 Cr₹15 Cr
₹8 Cr₹11 Cr₹4 Cr₹17 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025
₹53 Cr₹40 Cr
₹177 Cr₹41 Cr
₹177 Cr₹41 Cr
₹230 Cr₹80 Cr
₹25 Cr₹0
₹6 Cr₹5 Cr
₹4 L₹34 Cr
₹5 Cr₹2 Cr
₹37 L₹24 L
₹12 Cr₹41 Cr
₹42 Cr₹20 Cr
₹14 Cr₹4 Cr
₹38 Cr₹28 Cr
₹14 Cr₹8 Cr
₹108 Cr₹60 Cr
₹374 Cr₹181 Cr
₹25 L₹0
₹44 Cr₹67 Cr
₹84 Cr₹36 Cr
₹26 Cr₹13 Cr
₹58 Cr₹23 Cr
₹98 L₹0
₹98 L₹0
₹7 Cr₹0
₹66 Cr₹23 Cr
₹1 L₹91 L
₹113 Cr₹50 Cr
₹104 Cr₹75 Cr
₹4 Cr₹1 Cr
₹1 Cr₹1 Cr
₹86 Cr₹30 Cr
₹308 Cr₹158 Cr
₹201 Cr₹98 Cr
₹374 Cr₹181 Cr
₹43₹20
₹4₹2

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025
₹43 Cr₹27 Cr
₹5 Cr-₹56 L
-₹122 Cr-₹54 Cr
-₹75 Cr-₹28 Cr
-₹79 Cr-₹23 Cr
-₹36 Cr₹3 Cr
₹119 Cr₹19 Cr
₹3 Cr-₹82 L
₹1 Cr₹2 Cr
₹4 Cr₹1 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)17.73
Volume (₹)15.07 Cr
High (₹)20.00
Upper Circuit21.04
Low (₹)17.54
Lower Circuit14.04
Prev Close17.54
52W High (₹)20.00
Price19.57
52W Low (₹)10.20

Share Market Cap & Key Ratios Overview

M.Cap (₹)933.34 Cr
Div. Yield (%)0.00
PE Ratio32.73
Debt to Equity0.19
Price to Book2.57
Book Value4.33
EPS (TTM)0.54
Face Value2.00
ROE (%)18.73

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
DRREDDYNSE
LUPINNSE
MANKINDNSE
AHCLNSE
LTP
1W Low
1W High
Market cap (₹)
1840-59 (-3.11%)
1834
1907.80
4,47,236Cr
9322+222 (2.44%)
9119.50
9615
2,49,673Cr
4965.5+108.5 (2.23%)
4823
5000
1,87,460Cr
1119.1-0.9 (-0.08%)
1104.60
1167.70
1,11,521Cr
1366-19 (-1.37%)
1347.70
1398.40
1,11,484Cr
1969+129 (7.01%)
1832.70
1981.80
1,04,604Cr
1679.8+26.7 (1.62%)
1646
1704
96,031Cr
1165.5+14.5 (1.26%)
1130
1182
95,220Cr
2095-15 (-0.71%)
2058
2135.50
94,883Cr
2280-47.9 (-2.06%)
2222
2331.60
92,770Cr
19.57+3.89 (24.81%)
15.41
20
933Cr

Anlon Healthcare Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹15.65Cr; with other income of ₹6Lakh, profit before interest and tax came to ₹14.58Cr. Interest expense was ₹92.5Lakh; PBT before exceptional items stood at ₹13.66Cr. Cost mix (full year): raw materials ₹149.31Cr; employee cost ₹5.54Cr; depreciation ₹1.07Cr; other expenses ₹71.97Cr. Basis: consolidated annual results.

Anlon Healthcare Ltd Quaterly Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹15.65Cr; with other income of ₹6Lakh, profit before interest and tax came to ₹14.58Cr. Interest expense was ₹92.5Lakh, taking profit before tax to ₹13.66Cr.